Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates fitzhugh.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fitzhugh.ca Daily Mail and Mail on Sunday newspapers.
Federal health advisers have rejected the first-ever proposal to use MDMA as a treatment for PTSD. The nonbinding vote is a potential setback for psychedelic advocates hoping to move the
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates prpeak.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prpeak.com Daily Mail and Mail on Sunday newspapers.
David Alfandre, MD, MSPH, is a general internist and a clinician-educator. His special interests include medical decision-making, “against medical advice” discharges, and ethics consultation. Dr Alfandre completed his public health training at the Tulane School of Public Health and Tropical Medicine, followed by 2 years of service as a health educator in the Peace Corps. He graduated from Mount Sinai School of Medicine and then completed his internal medicine training at Columbia Presbyterian Hospital in New York. He is currently a health care ethicist at the VA National Center for Ethics in Health Care and an associate professor of medicine and population health at the NYU School of Medicine. He takes care of patients as a hospitalist teaching attending at the VA New York Harbor Health Care System. His twitter handle is @alfandremd.